Cargando…
High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease
Patients with marked calcification of the basal ganglia and cerebellum have traditionally been referred to as having Fahr's disease, but the nomenclature has been criticized for including heterogeneous etiology. We describe 3 patients with idiopathic bilateral striatopallidodentate calcinosis (...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905580/ https://www.ncbi.nlm.nih.gov/pubmed/20671856 http://dx.doi.org/10.1159/000313920 |
_version_ | 1782183978382393344 |
---|---|
author | Hozumi, Isao Kohmura, Akihiro Kimura, Akio Hasegawa, Tatsuya Honda, Akiko Hayashi, Yuichi Hashimoto, Kazunori Yamada, Megumi Sakurai, Takeo Tanaka, Yuji Satoh, Masahiko Inuzuka, Takashi |
author_facet | Hozumi, Isao Kohmura, Akihiro Kimura, Akio Hasegawa, Tatsuya Honda, Akiko Hayashi, Yuichi Hashimoto, Kazunori Yamada, Megumi Sakurai, Takeo Tanaka, Yuji Satoh, Masahiko Inuzuka, Takashi |
author_sort | Hozumi, Isao |
collection | PubMed |
description | Patients with marked calcification of the basal ganglia and cerebellum have traditionally been referred to as having Fahr's disease, but the nomenclature has been criticized for including heterogeneous etiology. We describe 3 patients with idiopathic bilateral striatopallidodentate calcinosis (IBSPDC). The patients were a 24-year-old man with mental deterioration, a 57-year-old man with parkinsonism and dementia, and a 76-year-old woman with dementia and mild parkinsonism. The former 2 patients showed severe calcification of the basal ganglia and cerebellum, and the latter patient showed severe calcification of the cerebellum. We found significantly increased levels of copper (Cu), zinc (Zn), iron (Fe) and magnesium (Mg), using inductively coupled plasma mass spectrometry in the CSF of all these 3 patients. The increased levels of Cu, Zn, Fe and Mg reflect the involvement of metabolism of several metals and/or metal-binding proteins during the progression of IBSPDC. More numerous patients with IBSPDC should be examined in other races to clarify the common mechanism of the disease and to investigate the specific treatment. |
format | Text |
id | pubmed-2905580 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-29055802010-07-29 High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease Hozumi, Isao Kohmura, Akihiro Kimura, Akio Hasegawa, Tatsuya Honda, Akiko Hayashi, Yuichi Hashimoto, Kazunori Yamada, Megumi Sakurai, Takeo Tanaka, Yuji Satoh, Masahiko Inuzuka, Takashi Case Rep Neurol Published: May 2010 Patients with marked calcification of the basal ganglia and cerebellum have traditionally been referred to as having Fahr's disease, but the nomenclature has been criticized for including heterogeneous etiology. We describe 3 patients with idiopathic bilateral striatopallidodentate calcinosis (IBSPDC). The patients were a 24-year-old man with mental deterioration, a 57-year-old man with parkinsonism and dementia, and a 76-year-old woman with dementia and mild parkinsonism. The former 2 patients showed severe calcification of the basal ganglia and cerebellum, and the latter patient showed severe calcification of the cerebellum. We found significantly increased levels of copper (Cu), zinc (Zn), iron (Fe) and magnesium (Mg), using inductively coupled plasma mass spectrometry in the CSF of all these 3 patients. The increased levels of Cu, Zn, Fe and Mg reflect the involvement of metabolism of several metals and/or metal-binding proteins during the progression of IBSPDC. More numerous patients with IBSPDC should be examined in other races to clarify the common mechanism of the disease and to investigate the specific treatment. S. Karger AG 2010-05-07 /pmc/articles/PMC2905580/ /pubmed/20671856 http://dx.doi.org/10.1159/000313920 Text en Copyright © 2010 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions. |
spellingShingle | Published: May 2010 Hozumi, Isao Kohmura, Akihiro Kimura, Akio Hasegawa, Tatsuya Honda, Akiko Hayashi, Yuichi Hashimoto, Kazunori Yamada, Megumi Sakurai, Takeo Tanaka, Yuji Satoh, Masahiko Inuzuka, Takashi High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease |
title | High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease |
title_full | High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease |
title_fullStr | High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease |
title_full_unstemmed | High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease |
title_short | High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease |
title_sort | high levels of copper, zinc, iron and magnesium, but not calcium, in the cerebrospinal fluid of patients with fahr's disease |
topic | Published: May 2010 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905580/ https://www.ncbi.nlm.nih.gov/pubmed/20671856 http://dx.doi.org/10.1159/000313920 |
work_keys_str_mv | AT hozumiisao highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease AT kohmuraakihiro highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease AT kimuraakio highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease AT hasegawatatsuya highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease AT hondaakiko highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease AT hayashiyuichi highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease AT hashimotokazunori highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease AT yamadamegumi highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease AT sakuraitakeo highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease AT tanakayuji highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease AT satohmasahiko highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease AT inuzukatakashi highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease |